Physician profile
Jack M Hua
NPI 1649657214
$25,137.15
in general payments reported to CMS, 2019-2025
27 companies · $5,977 in 2025
The $5,977 reported for 2025 was more than what 91% of Plastic Surgery Within The Head and Neck providers received nationally (typical 2025 total: $300).
See the full distribution for Plastic Surgery Within the Head and Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $1,803 · 2021: $2,392 · 2022: $3,213 · 2023: $4,691 · 2024: $6,791 · 2025: $5,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $4,198 · Education: $19.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,241.15 |
| Travel and Lodging | $4,198.34 |
| Education | $19.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $7,371.57 | 2020-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Cap |
| Abbvie INC. | $3,095.75 | 2023-2025 | |
| Tela Bio, INC. | $2,605.51 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Revance Therapeutics, INC. | $1,918.87 | 2024-2025 | Daxxify, Daxi |
| Allergan, INC. | $1,535.83 | 2020-2022 | |
| Integra Lifesciences Corporation | $1,281.23 | 2021-2024 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $1,111.35 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Stryker Corporation | $920.59 | 2022-2025 | 1788, Na, Spy-Phi System |
| Acera Surgical, INC. | $889.84 | 2022-2024 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $808.56 | 2019-2024 | Matrixmandible, Trumatch |
| Zimmer Biomet Holdings, INC. | $716.27 | 2020-2024 | |
| Musculoskeletal Transplant Foundation INC. | $592.96 | 2025 | |
| Medline Industries LP | $387.98 | 2020-2021 | |
| Acell, INC. | $277.44 | 2020 | |
| Checkpoint Surgical, INC | $245.32 | 2021-2023 | Checkpoint Stimulators |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biowound Solutions, INC. | $191.20 | 2025 | Bio-Connekt |
| Sientra, INC. | $181.37 | 2022 | |
| Kerecis Limited | $163.32 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $149.59 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $129.04 | 2022-2025 | Exparel |
| Davol INC. | $124.69 | 2022 | |
| Aroa Biosurgery Incorporated | $115.42 | 2022 | |
| Merz North America, INC. | $111.01 | 2024-2025 | |
| Medical Device Business Services, INC. | $109.63 | 2019-2023 | Vistaseal |
| Kls-Martin L.P. | $44.71 | 2024-2025 | |
| Galderma Laboratories, L.P. | $41.63 | 2024-2025 | |
| Motiva USA, LLC | $16.47 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Hua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.